New Once-a-Day pill could ease lifelong burden of rare copper disease
Disease control
Not yet recruiting
This study is testing a new, once-daily version of a copper-removing drug (trientine) against the current standard treatment (d-Penicillamine) for people newly diagnosed with Wilson's disease. It aims to see if the new formulation is effective, safe, and easier to stick with than…
Phase: PHASE3 • Sponsor: Orphalan • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC